| Palonosetron |
EU/1/04/306/001 |
ALOXI, Solution for injection, 250 mcg/5 ml, -, Pack: 1 |
Helsinn Birex Pharmaceuticals Ltd., Ирландия |
Helsinn Birex Pharmaceuticals Ltd, Ireland |
55.47 |
11.09 |
66.56 |
4% |
2.22 |
57.69 |
11.54 |
69.23 |
16% |
8.88 |
66.57 |
13.31 |
79.88 |
Прот. № 220/20.04.2017 г. |
НСР-5458/16.01.2015; НСР-9209/ 05.05.2016; НСР-13552/18.08.2017; НСР-17088/26.10.2018 |
10.11.2018 |
02.12.2018 |
Активен |
3521 |
| Palonosetron |
EU/1/04/306/001 |
ALOXI, Solution for injection, 250 mcg/5 ml, -, Pack: 1 |
Helsinn Birex Pharmaceuticals Ltd., Ирландия |
Helsinn Birex Pharmaceuticals Ltd, Ireland |
68.53 |
13.71 |
82.24 |
4% |
2.74 |
71.27 |
14.25 |
85.52 |
16% |
10.96 |
82.23 |
16.45 |
98.68 |
Прот. № 220/20.04.2017 г. |
НСР-5458/16.01.2015; НСР-9209/ 05.05.2016; НСР-13552/18.08.2017 |
02.09.2017 |
02.10.2017 |
Неактивен |
3521 |
| Palonosetron |
EU/1/04/306/001 |
ALOXI, Solution for injection, 250 mcg/5 ml, -, Pack: 1 |
Helsinn Birex Pharmaceuticals Ltd., Ирландия |
Helsinn Birex Pharmaceuticals Ltd, Ireland |
107.75 |
21.55 |
129.3 |
4% |
4.31 |
112.06 |
22.41 |
134.47 |
16% |
17.24 |
129.3 |
25.86 |
155.16 |
Прот. № 220/20.04.2017 г. |
НСР-5458/16.01.2015; НСР-9209/ 05.05.2016 |
02.06.2016 |
02.05.2017 |
Неактивен |
3521 |
| Palonosetron |
EU/1/04/306/001 |
ALOXI, Solution for injection, 0,05 mg/ml - 5 ml, mg, Pack: 1 |
Helsinn Birex Pharmaceuticals Ltd., Ирландия |
Helsinn Birex Pharmaceuticals Ltd, Ireland |
107.75 |
21.55 |
129.3 |
4% |
4.31 |
112.06 |
22.41 |
134.47 |
16% |
17.24 |
129.3 |
25.86 |
155.16 |
|
НСР-5458/16.01.2015; НСР-9209/ 05.05.2016 |
02.06.2016 |
02.06.2016 |
Неактивен |
3521 |
| Palonosetron |
EU/1/04/306/001 |
ALOXI, Solution for injection, 0,05 mg/ml - 5 ml, mg, Pack: 1 |
Helsinn Birex Pharmaceuticals Ltd., Ирландия |
Helsinn Birex Pharmaceuticals Ltd, Ireland |
108.65 |
21.73 |
130.38 |
4% |
4.35 |
113 |
22.6 |
135.6 |
16% |
17.38 |
130.38 |
26.08 |
156.46 |
|
НСР-5458/16.01.2015 |
02.02.2015 |
02.02.2015 |
Неактивен |
3521 |
| Palonosetron |
EU/1/04/306/001 |
ALOXI, Solution for injection, 0,05 mg/ml - 5 ml, mg, Pack: 1 |
Helsinn Birex Pharmaceuticals Ltd., Ирландия |
Helsinn Birex Pharmaceuticals Ltd, Ireland |
116.92 |
23.38 |
140.3 |
4% |
4.68 |
121.6 |
24.32 |
145.92 |
16% |
18.71 |
140.31 |
28.06 |
168.37 |
|
НСР-3177/07.04.2014 |
12.05.2014 |
12.05.2014 |
Неактивен |
3521 |
| Palonosetron |
EU/1/04/306/001 |
ALOXI, Solution for injection, 0,05 mg/ml - 5 ml, mg, Pack: 1 |
Helsinn Birex Pharmaceuticals Ltd., Ирландия |
Helsinn Birex Pharmaceuticals Ltd, Ireland |
124.47 |
24.89 |
149.36 |
4% |
4.98 |
129.45 |
25.89 |
155.34 |
16% |
19.92 |
149.37 |
29.87 |
179.24 |
върната жалба от Комисия по прозрачност с писмо № КЦР-589/10.04.2013 |
КЦРР-389/29.03.2012 |
02.07.2013 |
02.07.2013 |
Неактивен |
3521 |
| Palonosetron |
EU/1/04/306/001 |
ALOXI, Solution for injection, 0,05 mg/ml - 5 ml, mg, Pack: 1 |
Helsinn Birex Pharmaceuticals Ltd., Ирландия |
Helsinn Birex Pharmaceuticals Ltd, Ireland |
131.04 |
26.21 |
157.25 |
4% |
5.24 |
136.28 |
27.26 |
163.54 |
16% |
20.97 |
157.25 |
31.45 |
188.7 |
|
КЦ-421/10.01.2009 |
06.02.2009 |
06.02.2009 |
Неактивен |
3521 |
| Cefepime |
20140246 |
Alphacef, Powder for solution for injection, 1, g, Pack: 10 |
Medochemie Ltd., Кипър |
Medochemie Ltd., (Factory C), Mich. Erakleous, Agios Athanasios Industrial Area, Limassol, Кипър |
94.16 |
18.83 |
112.99 |
4% |
3.77 |
97.93 |
19.59 |
117.52 |
16% |
15.07 |
113 |
22.6 |
135.6 |
|
НСР-6706/16.07.2015.; НСР-16967/12.10.2018 |
27.10.2018 |
02.11.2018 |
Активен |
4041 |
| Cefepime |
20140246 |
Alphacef, Powder for solution for injection, 1, g, Pack: 10 |
Medochemie Ltd., Кипър |
Medochemie Ltd., (Factory C), Mich. Erakleous, Agios Athanasios Industrial Area, Limassol, Кипър |
175.44 |
35.09 |
210.53 |
4% |
7.02 |
182.46 |
36.49 |
218.95 |
16% |
25 |
207.46 |
41.49 |
248.95 |
|
НСР-6706/16.07.2015. |
01.08.2015 |
01.08.2015 |
Неактивен |
4041 |
| Alfacalcidol |
II - 15922/29.12.2006 |
Alpha D3, Capsule, soft, 0.5, mcg, Pack: 30 |
Тева Фармасютикълс България ЕООД, България |
Teva Pharmaceutical Industries Limited, Israel
Teva Pharma BV, The Netherlands
Pharmachemie B.V., The Netherlands |
8.02 |
1.6 |
9.62 |
7% |
0.56 |
8.58 |
1.72 |
10.3 |
20% |
1.6 |
10.18 |
2.04 |
12.22 |
Цената се заличава с решение НСР-295307.03.2014; Отхвърлена жалба от Комисия по прозрачност с решение КП-45/05.03.2015 и НСР-2005/11.12.2013 |
НСР-1807/25.11.2013 |
11.12.2013 |
11.12.2013 |
Заличен |
2306 |
| Alfacalcidol |
II - 15921/29.12.2006 |
Alpha D3, Capsule, soft, 0.25, mcg, Pack: 30 |
Тева Фармасютикълс България ЕООД, България |
Teva Pharmaceutical Industries Limited, Israel
Teva Pharma BV, The Netherlands
Pharmachemie B.V., The Netherlands |
4.01 |
0.8 |
4.81 |
7% |
0.28 |
4.29 |
0.86 |
5.15 |
20% |
0.8 |
5.09 |
1.02 |
6.11 |
Цената се заличава с решение НСР-2715/06.02.2014 |
НСР-1807/25.11.2013 |
11.12.2013 |
11.12.2013 |
Заличен |
2305 |
| Alfacalcidol |
II - 15923/29.12.2006 |
Alpha D3, Capsule, soft, 1, mcg, Pack: 30 |
Тева Фармасютикълс България ЕООД, България |
Teva Pharmaceutical Industries Limited, Israel
Teva Pharma BV, The Netherlands
Pharmachemie B.V., The Netherlands |
13.85 |
2.77 |
16.62 |
6% |
0.83 |
14.68 |
2.94 |
17.62 |
18% |
2.49 |
17.17 |
3.43 |
20.6 |
Цената се заличава с решение НСР-2951/07.03.2014 |
КЦ-700/09.03.2009 |
24.03.2009 |
24.03.2009 |
Заличен |
659 |
| Alfacalcidol |
II - 15922/29.12.2006 |
Alpha D3, Capsule, soft, 0.5, mcg, Pack: 30 |
Тева Фармасютикълс България ЕООД, България |
Teva Pharmaceutical Industries Limited, Israel
Teva Pharma BV, The Netherlands
Pharmachemie B.V., The Netherlands |
9.06 |
1.81 |
10.87 |
7% |
0.63 |
9.69 |
1.94 |
11.63 |
20% |
1.81 |
11.5 |
2.3 |
13.8 |
|
КЦ-700/09.03.2009 |
24.03.2009 |
24.03.2009 |
Неактивен |
2306 |
| Alfacalcidol |
II - 15921/29.12.2006 |
Alpha D3, Capsule, soft, 0.25, mcg, Pack: 30 |
Тева Фармасютикълс България ЕООД, България |
Teva Pharmaceutical Industries Limited, Israel
Teva Pharma BV, The Netherlands
Pharmachemie B.V., The Netherlands |
6.2 |
1.24 |
7.44 |
7% |
0.43 |
6.63 |
1.33 |
7.96 |
20% |
1.24 |
7.87 |
1.57 |
9.44 |
|
КЦ-700/09.03.2009 |
24.03.2009 |
24.03.2009 |
Неактивен |
2305 |
| Coagulation factor IX |
EU/1/16/1098/005 |
Alprolix, Powder and solvent for solution for injection, 3000, IU, Pack: 1 vial + 1 pre-filled syringe + 1 plunger rod + 1 vial adapter + 1 infusion set + 2 swabs + 2 plasters + 1 gauze |
Swedish Orphan Biovitrum AB, Швеция |
Swedish Orphan Biovitrum AB (publ), Strandbergsgatan 49, 11276 Stockholm, Швеция |
5486.34 |
1097.27 |
6583.61 |
4% |
10 |
5496.34 |
1099.27 |
6595.61 |
16% |
25 |
5521.34 |
1104.27 |
6625.61 |
|
НСР-14169/13.10.2017; КП-31/06.03.2019 и НСР-17528/13.12.2018; НСР-20369/12.12.2019; НСР-22157/13.08.2020 |
28.08.2020 |
02.09.2020 |
Активен |
15908 |
| Coagulation factor IX |
EU/1/16/1098/005 |
Alprolix, Powder and solvent for solution for injection, 3000, IU, Pack: 1 vial + 1 pre-filled syringe + 1 plunger rod + 1 vial adapter + 1 infusion set + 2 swabs + 2 plasters + 1 gauze |
Swedish Orphan Biovitrum AB, Швеция |
Swedish Orphan Biovitrum AB (publ), Strandbergsgatan 49, 11276 Stockholm, Швеция |
5617.93 |
1123.59 |
6741.52 |
4% |
10 |
5627.93 |
1125.59 |
6753.52 |
16% |
25 |
5652.93 |
1130.59 |
6783.52 |
|
НСР-14169/13.10.2017; КП-31/06.03.2019 и НСР-17528/13.12.2018; НСР-20369/12.12.2019 |
27.12.2019 |
02.01.2020 |
Неактивен |
15908 |
| Coagulation factor IX |
EU/1/16/1098/004 |
Alprolix, Powder and solvent for solution for injection, 2000, IU, Pack: 1 vial + 1 pre-filled syringe + 1 plunger rod + 1 vial adapter + 1 infusion set + 2 swabs + 2 plasters + 1 gauze |
Swedish Orphan Biovitrum AB, Швеция |
Swedish Orphan Biovitrum AB (publ), Strandbergsgatan 49, 11276 Stockholm, Швеция |
3657.56 |
731.51 |
4389.07 |
4% |
10 |
3667.56 |
733.51 |
4401.07 |
16% |
25 |
3692.56 |
738.51 |
4431.07 |
|
НСР-14169/13.10.2017; КП-31/06.03.2019 и НСР-17526/13.12.2018; НСР-20370/12.12.2019; НСР-22158/13.08.2020 |
28.08.2020 |
02.09.2020 |
Активен |
15907 |
| Coagulation factor IX |
EU/1/16/1098/004 |
Alprolix, Powder and solvent for solution for injection, 2000, IU, Pack: 1 vial + 1 pre-filled syringe + 1 plunger rod + 1 vial adapter + 1 infusion set + 2 swabs + 2 plasters + 1 gauze |
Swedish Orphan Biovitrum AB, Швеция |
Swedish Orphan Biovitrum AB (publ), Strandbergsgatan 49, 11276 Stockholm, Швеция |
3745.28 |
749.06 |
4494.34 |
4% |
10 |
3755.28 |
751.06 |
4506.34 |
16% |
25 |
3780.28 |
756.06 |
4536.34 |
|
НСР-14169/13.10.2017; КП-31/06.03.2019 и НСР-17526/13.12.2018; НСР-20370/12.12.2019 |
27.12.2019 |
02.01.2020 |
Неактивен |
15907 |
| Coagulation factor IX |
EU/1/16/1098/003 |
Alprolix, Powder and solvent for solution for injection, 1000, IU, Pack: 1 vial + 1 pre-filled syringe + 1 plunger rod + 1 vial adapter + 1 infusion set + 2 swabs + 2 plasters + 1 gauze |
Swedish Orphan Biovitrum AB, Швеция |
Swedish Orphan Biovitrum AB (publ), Strandbergsgatan 49, 11276 Stockholm, Швеция |
1828.78 |
365.76 |
2194.54 |
4% |
10 |
1838.78 |
367.76 |
2206.54 |
16% |
25 |
1863.78 |
372.76 |
2236.54 |
|
НСР-14169/13.10.2017; КП-31/06.03.2019 и НСР-17525/13.12.2018; НСР-20371/12.12.2019; НСР-22159/13.08.2020 |
28.08.2020 |
02.09.2020 |
Активен |
15906 |
| Coagulation factor IX |
EU/1/16/1098/003 |
Alprolix, Powder and solvent for solution for injection, 1000, IU, Pack: 1 vial + 1 pre-filled syringe + 1 plunger rod + 1 vial adapter + 1 infusion set + 2 swabs + 2 plasters + 1 gauze |
Swedish Orphan Biovitrum AB, Швеция |
Swedish Orphan Biovitrum AB (publ), Strandbergsgatan 49, 11276 Stockholm, Швеция |
1872.65 |
374.53 |
2247.18 |
4% |
10 |
1882.65 |
376.53 |
2259.18 |
16% |
25 |
1907.65 |
381.53 |
2289.18 |
|
НСР-14169/13.10.2017; КП-31/06.03.2019 и НСР-17525/13.12.2018; НСР-20371/12.12.2019 |
27.12.2019 |
02.01.2020 |
Неактивен |
15906 |
| Coagulation factor IX |
EU/1/16/1098/002 |
Alprolix, Powder and solvent for solution for injection, 500, IU, Pack: 1 vial + 1 pre-filled syringe + 1 plunger rod + 1 vial adapter + 1 infusion set + 2 swabs + 2 plasters + 1 gauze |
Swedish Orphan Biovitrum AB, Швеция |
Swedish Orphan Biovitrum AB (publ), Strandbergsgatan 49, 11276 Stockholm, Швеция |
914.39 |
182.88 |
1097.27 |
4% |
10 |
924.39 |
184.88 |
1109.27 |
16% |
25 |
949.39 |
189.88 |
1139.27 |
|
НСР-14169/13.10.2017; КП-31/06.03.2019 и НСР-17515/13.12.2018; НСР-20372/12.12.2019; НСР-22160/13.08.2020 |
28.08.2020 |
02.09.2020 |
Активен |
15905 |
| Coagulation factor IX |
EU/1/16/1 098/002 |
Alprolix, Powder and solvent for solution for injection, 500, IU, Pack: 1 vial + 1 pre-filled syringe + 1 plunger rod + 1 vial adapter + 1 infusion set + 2 swabs + 2 plasters + 1 gauze |
Swedish Orphan Biovitrum AB, Швеция |
Swedish Orphan Biovitrum AB (publ), Strandbergsgatan 49, 11276 Stockholm, Швеция |
936.31 |
187.26 |
1123.57 |
4% |
10 |
946.31 |
189.26 |
1135.57 |
16% |
25 |
971.31 |
194.26 |
1165.57 |
|
НСР-14169/13.10.2017; КП-31/06.03.2019 и НСР-17515/13.12.2018; НСР-20372/12.12.2019 |
27.12.2019 |
02.01.2020 |
Неактивен |
15905 |
| Coagulation factor IX |
EU/1/16/1098/001 |
Alprolix, Powder and solvent for solution for injection, 250, IU, Pack: 1 vial + 1 pre-filled syringe + 1 plunger rod + 1 vial adapter + 1 infusion set + 2 swabs + 2 plasters + 1 gauze |
Swedish Orphan Biovitrum AB, Швеция |
Swedish Orphan Biovitrum AB (publ), Strandbergsgatan 49, 11276 Stockholm, Швеция |
457.19 |
91.44 |
548.63 |
4% |
10 |
467.19 |
93.44 |
560.63 |
16% |
25 |
492.19 |
98.44 |
590.63 |
|
НСР-14169/13.10.2017; КП-31/06.03.2019 и НСР-17527/13.12.2018; НСР-20373/12.12.2019; НСР-22163/13.08.2020 |
28.08.2020 |
02.09.2020 |
Активен |
15904 |
| Coagulation factor IX |
EU/1/16/1098/001 |
Alprolix, Powder and solvent for solution for injection, 250, IU, Pack: 1 vial + 1 pre-filled syringe + 1 plunger rod + 1 vial adapter + 1 infusion set + 2 swabs + 2 plasters + 1 gauze |
Swedish Orphan Biovitrum AB, Швеция |
Swedish Orphan Biovitrum AB (publ), Strandbergsgatan 49, 11276 Stockholm, Швеция |
468.17 |
93.63 |
561.8 |
4% |
10 |
478.17 |
95.63 |
573.8 |
16% |
25 |
503.17 |
100.63 |
603.8 |
|
НСР-14169/13.10.2017; КП-31/06.03.2019 и НСР-17527/13.12.2018; НСР-20373/12.12.2019 |
27.12.2019 |
02.01.2020 |
Неактивен |
15904 |